New York Medical College Clinical Trial Becomes First to Administer Novel Inhaled mRNA Therapy to a Patient with Cystic Fibrosis in the United States - River Journal Online - News for Tarrytown, Sleepy Hollow, Irvington, Ossining, Briarcliff Manor, Croton

Valencia Plaza

Factuality

Ownership

VALÈNCIA. (EP) The Universitari i Politècnic La Fe Hospital has been incorporated into the Clinical Trials Network of the European Society of Cystic Fibrosis (ECFS), which "enlarges therapeutic options for patients, both adults and paediatrics, while allowing to deepen the personalization of their treatments."Today, the network consists of 68 centers from 20 countries. In Spain, only three hospitals have been incorporated: the Vall d'Hebron, La …

riverjournalonline.com

Factuality

Ownership

New York Medical College Clinical Trial Becomes First to Administer Novel Inhaled mRNA Therapy to a Patient with Cystic Fibrosis in the United States - River Journal Online - News for Tarrytown, Sleepy Hollow, Irvington, Ossining, Briarcliff Manor, Croton

New York Medical College (NYMC), in collaboration with ReCode Therapeutics, a clinical-stage genetic medicines company, today announced that the first participant has been dosed with RCT2100 — a novel investigational inhaled messenger RNA (mRNA) therapy for people with cystic fibrosis (CF). This clinical trial aims to assess the safety and tolerability of RCT2100, providing new hope for people who do not respond to existing CFTR modulator treatm…